EDOCALD

Early Detection of Cancer using Lasers Demonstrator

Coordinatore	2M Engineering Limited    more  Organization address address: SIDNEY STREET 80 city: FOLKSTONE postcode: CT19 6HQ contact info Titolo: Mrs. Nome: Gillian Cognome: Mimnagh Email: send email Telefono: +31 40 2982020 Fax: +31 40 2982164
Nazionalità Coordinatore	United Kingdom [UK]
Totale costo	1˙849˙396 €
EC contributo	1˙165˙000 €
Programma	FP7-SME Specific Programme "Capacities": Research for the benefit of SMEs
Code Call	FP7-SME-2013
Funding Scheme	CP
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-10-01   -   2015-09-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	2M Engineering Limited  Organization address address: SIDNEY STREET 80 city: FOLKSTONE postcode: CT19 6HQ contact info Titolo: Mrs. Nome: Gillian Cognome: Mimnagh Email: send email Telefono: +31 40 2982020 Fax: +31 40 2982164	UK (FOLKSTONE)	coordinator	499˙280.00
2	UNIVERSITY OF DUNDEE  Organization address address: Nethergate city: DUNDEE postcode: DD1 4HN contact info Titolo: Mr. Nome: Neil Cognome: Stewart Email: send email Telefono: +44 1382633894	UK (DUNDEE)	participant	252˙120.80
3	COMPOUND SEMICONDUCTOR TECHNOLOGIES GLOBAL LIMITED  Organization address address: "Block 6, West of Scotland Science Park, Maryhill Road" city: Glasgow postcode: G20 0SP contact info Titolo: Mrs. Nome: Mary Cognome: Kane Email: send email Telefono: +44 1698722072	UK (Glasgow)	participant	209˙820.00
4	FOCE TECHNOLOGY INTERNATIONAL BV  Organization address address: WALDFEUCHTERBAAN 94 city: MARIA HOOP postcode: 6105 BN contact info Titolo: Dr. Nome: Marcel Cognome: Schemmann Email: send email Telefono: +31 651660823 Fax: +31 475 851912	NL (MARIA HOOP)	participant	111˙829.20
5	TOP-GAN SP ZOO  Organization address address: UL. SOKOLOWSKA 29/37 city: WARSZAWA postcode: 01 142 contact info Titolo: Prof. Nome: Mike Cognome: Leszczy?sk Email: send email Telefono: +48 228760315	PL (WARSZAWA)	participant	91˙950.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'According to the WHO statistics, cancer causes around 7.6 million deaths worldwide each year. Deaths from cancer are projected to rise to 17 million in 2030. Changes in lifestyle and improved prevention and screening policies could prevent up to 40% of all cancer cases.

On 2 December 2003 the Health Ministers of the European Union unanimously adopted a recommendation on cancer screening based on the developments and experience in the Europe Against Cancer program. The Recommendation of the Council of the European Union spells out fundamental principles of best practice in early detection of cancer and invites EU Member States to take common action to implement national cancer screening programs.

Reports from the US state that Oral Cancer is the most expensive to treat. Most oral cancers require costly and disfiguring medical intervention, and even then the five-year survival rate is only 57%. There are 124.000 new cases diagnosed each year. This gives an additional cost to the medical health care system of €6.944B per year.

Historically the death rate associated with this cancer is particularly high not because it is hard to discover or diagnose, but due to the cancer being routinely discovered late in its development. Today, there is still no comprehensive program to opportunistically screen for the disease, and without that; late stage discovery and high mortality rates are most likely to continue.

In a previous Research for SMEs project: (EDOCAL), the SMEs 2M, CST and TG developed a preliminary test system for early cancer detection using state of the art telecom laser technology. This project finished on 31.12.2011 and the results achieved in were in line with the goals set put at the start of the project.

Our objective in this project is to use the results of the research to build and validate the demonstrator in a clinical setting and subsequently to commercialise the first low cost screening tool for early detection of oral cancers.'